Impact of STIMUlant and osmotic LAXatives (STIMULAX trial) on gastrointestinal recovery after colorectal surgery: randomized clinical trial

BACKGROUNDRecovery of gastrointestinal (GI) function is often delayed after colorectal surgery. Enhanced recovery protocols (ERPs) recommend routine laxative use, but evidence of benefit is unclear. This study aimed to investigate whether the addition of multimodal laxatives to an ERP improves retur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of surgery 2021-07, Vol.108 (7), p.797-803
Hauptverfasser: Dudi-Venkata, N N, Kroon, H M, Bedrikovetski, S, Lewis, M, Lawrence, M J, Hunter, R A, Moore, J W, Thomas, M L, Sammour, T
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 803
container_issue 7
container_start_page 797
container_title British journal of surgery
container_volume 108
creator Dudi-Venkata, N N
Kroon, H M
Bedrikovetski, S
Lewis, M
Lawrence, M J
Hunter, R A
Moore, J W
Thomas, M L
Sammour, T
description BACKGROUNDRecovery of gastrointestinal (GI) function is often delayed after colorectal surgery. Enhanced recovery protocols (ERPs) recommend routine laxative use, but evidence of benefit is unclear. This study aimed to investigate whether the addition of multimodal laxatives to an ERP improves return of GI function in patients undergoing colorectal surgery. METHODSThis was a single-centre, parallel, open-label RCT. All adult patients undergoing elective colorectal resection or having stoma formation or reversal at the Royal Adelaide Hospital between August 2018 and May 2020 were recruited into the study. The STIMULAX group received oral Coloxyl® with senna and macrogol, with a sodium phosphate enema in addition for right-sided operations. The control group received standard ERP postoperative care. The primary outcome was GI-2, a validated composite measure defined as the interval from surgery until first passage of stool and tolerance of solid intake for 24 h in the absence of vomiting. Secondary outcomes were the incidence of prolonged postoperative ileus (POI), duration of hospital stay, and postoperative complications. The analysis was performed on an intention-to-treat basis. RESULTSOf a total of 170 participants, 85 were randomized to each group. Median GI-2 was 1 day shorter in the STIMULAX compared with the control group (median 2  (i.q.r. 1.5-4) versus 3 (2-5.5) days; 95 per cent c.i. -1 to 0 days; P = 0.029). The incidence of prolonged POI was lower in the STIMULAX group (22 versus 38 per cent; relative risk reduction 42 per cent; P = 0.030). There was no difference in duration of hospital day or 30-day postoperative complications (including anastomotic leak) between the STIMULAX and control groups. CONCLUSIONRoutine postoperative use of multimodal laxatives after elective colorectal surgery results in earlier recovery of gastrointestinal function and reduces the incidence of prolonged POI. Registration number: ACTRN12618001261202 (www.anzctr.org.au).
doi_str_mv 10.1093/bjs/znab140
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2542362085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2542362085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c267t-837d2fb0642e0c31f841f32efa3ffa6a415b3094f8087bdf9ebc26b136d4b7f43</originalsourceid><addsrcrecordid>eNotkEtLAzEQgIMgWKsn_8Ac62FtXvuot1J8FFY82IK3kmSTkpLd1CQt2L_gnzZUT8PMN_MxMwjdEfxA8IxN5S5OT4OQhOMLNCKsKgtKquYKXce4w5gwXNIR-ln2e6ESeAMfq-Xb2okhgRg68LH3ySpo558i2aOOMDk35BxSsMLdgx9gK2IK3g5Jx2QH4SBo5Y86fIMwSQdQ3vlcSpnEQ9hm8Agh631vT7oD5exgVYZn4w26NMJFffsfx2j9_LRavBbt-8tyMW8LRas6FQ2rO2okrjjVWDFiGk4Mo9oIZoyoBCelZHjGTYObWnZmpmUelPkDHZe14WyMJn_effBfh7z5prdRaZdv1_4QN7TklFUUNyX7BTJsZ1k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2542362085</pqid></control><display><type>article</type><title>Impact of STIMUlant and osmotic LAXatives (STIMULAX trial) on gastrointestinal recovery after colorectal surgery: randomized clinical trial</title><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Dudi-Venkata, N N ; Kroon, H M ; Bedrikovetski, S ; Lewis, M ; Lawrence, M J ; Hunter, R A ; Moore, J W ; Thomas, M L ; Sammour, T</creator><creatorcontrib>Dudi-Venkata, N N ; Kroon, H M ; Bedrikovetski, S ; Lewis, M ; Lawrence, M J ; Hunter, R A ; Moore, J W ; Thomas, M L ; Sammour, T</creatorcontrib><description>BACKGROUNDRecovery of gastrointestinal (GI) function is often delayed after colorectal surgery. Enhanced recovery protocols (ERPs) recommend routine laxative use, but evidence of benefit is unclear. This study aimed to investigate whether the addition of multimodal laxatives to an ERP improves return of GI function in patients undergoing colorectal surgery. METHODSThis was a single-centre, parallel, open-label RCT. All adult patients undergoing elective colorectal resection or having stoma formation or reversal at the Royal Adelaide Hospital between August 2018 and May 2020 were recruited into the study. The STIMULAX group received oral Coloxyl® with senna and macrogol, with a sodium phosphate enema in addition for right-sided operations. The control group received standard ERP postoperative care. The primary outcome was GI-2, a validated composite measure defined as the interval from surgery until first passage of stool and tolerance of solid intake for 24 h in the absence of vomiting. Secondary outcomes were the incidence of prolonged postoperative ileus (POI), duration of hospital stay, and postoperative complications. The analysis was performed on an intention-to-treat basis. RESULTSOf a total of 170 participants, 85 were randomized to each group. Median GI-2 was 1 day shorter in the STIMULAX compared with the control group (median 2  (i.q.r. 1.5-4) versus 3 (2-5.5) days; 95 per cent c.i. -1 to 0 days; P = 0.029). The incidence of prolonged POI was lower in the STIMULAX group (22 versus 38 per cent; relative risk reduction 42 per cent; P = 0.030). There was no difference in duration of hospital day or 30-day postoperative complications (including anastomotic leak) between the STIMULAX and control groups. CONCLUSIONRoutine postoperative use of multimodal laxatives after elective colorectal surgery results in earlier recovery of gastrointestinal function and reduces the incidence of prolonged POI. Registration number: ACTRN12618001261202 (www.anzctr.org.au).</description><identifier>EISSN: 1365-2168</identifier><identifier>DOI: 10.1093/bjs/znab140</identifier><language>eng</language><ispartof>British journal of surgery, 2021-07, Vol.108 (7), p.797-803</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c267t-837d2fb0642e0c31f841f32efa3ffa6a415b3094f8087bdf9ebc26b136d4b7f43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Dudi-Venkata, N N</creatorcontrib><creatorcontrib>Kroon, H M</creatorcontrib><creatorcontrib>Bedrikovetski, S</creatorcontrib><creatorcontrib>Lewis, M</creatorcontrib><creatorcontrib>Lawrence, M J</creatorcontrib><creatorcontrib>Hunter, R A</creatorcontrib><creatorcontrib>Moore, J W</creatorcontrib><creatorcontrib>Thomas, M L</creatorcontrib><creatorcontrib>Sammour, T</creatorcontrib><title>Impact of STIMUlant and osmotic LAXatives (STIMULAX trial) on gastrointestinal recovery after colorectal surgery: randomized clinical trial</title><title>British journal of surgery</title><description>BACKGROUNDRecovery of gastrointestinal (GI) function is often delayed after colorectal surgery. Enhanced recovery protocols (ERPs) recommend routine laxative use, but evidence of benefit is unclear. This study aimed to investigate whether the addition of multimodal laxatives to an ERP improves return of GI function in patients undergoing colorectal surgery. METHODSThis was a single-centre, parallel, open-label RCT. All adult patients undergoing elective colorectal resection or having stoma formation or reversal at the Royal Adelaide Hospital between August 2018 and May 2020 were recruited into the study. The STIMULAX group received oral Coloxyl® with senna and macrogol, with a sodium phosphate enema in addition for right-sided operations. The control group received standard ERP postoperative care. The primary outcome was GI-2, a validated composite measure defined as the interval from surgery until first passage of stool and tolerance of solid intake for 24 h in the absence of vomiting. Secondary outcomes were the incidence of prolonged postoperative ileus (POI), duration of hospital stay, and postoperative complications. The analysis was performed on an intention-to-treat basis. RESULTSOf a total of 170 participants, 85 were randomized to each group. Median GI-2 was 1 day shorter in the STIMULAX compared with the control group (median 2  (i.q.r. 1.5-4) versus 3 (2-5.5) days; 95 per cent c.i. -1 to 0 days; P = 0.029). The incidence of prolonged POI was lower in the STIMULAX group (22 versus 38 per cent; relative risk reduction 42 per cent; P = 0.030). There was no difference in duration of hospital day or 30-day postoperative complications (including anastomotic leak) between the STIMULAX and control groups. CONCLUSIONRoutine postoperative use of multimodal laxatives after elective colorectal surgery results in earlier recovery of gastrointestinal function and reduces the incidence of prolonged POI. Registration number: ACTRN12618001261202 (www.anzctr.org.au).</description><issn>1365-2168</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNotkEtLAzEQgIMgWKsn_8Ac62FtXvuot1J8FFY82IK3kmSTkpLd1CQt2L_gnzZUT8PMN_MxMwjdEfxA8IxN5S5OT4OQhOMLNCKsKgtKquYKXce4w5gwXNIR-ln2e6ESeAMfq-Xb2okhgRg68LH3ySpo558i2aOOMDk35BxSsMLdgx9gK2IK3g5Jx2QH4SBo5Y86fIMwSQdQ3vlcSpnEQ9hm8Agh631vT7oD5exgVYZn4w26NMJFffsfx2j9_LRavBbt-8tyMW8LRas6FQ2rO2okrjjVWDFiGk4Mo9oIZoyoBCelZHjGTYObWnZmpmUelPkDHZe14WyMJn_effBfh7z5prdRaZdv1_4QN7TklFUUNyX7BTJsZ1k</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Dudi-Venkata, N N</creator><creator>Kroon, H M</creator><creator>Bedrikovetski, S</creator><creator>Lewis, M</creator><creator>Lawrence, M J</creator><creator>Hunter, R A</creator><creator>Moore, J W</creator><creator>Thomas, M L</creator><creator>Sammour, T</creator><scope>7X8</scope></search><sort><creationdate>20210701</creationdate><title>Impact of STIMUlant and osmotic LAXatives (STIMULAX trial) on gastrointestinal recovery after colorectal surgery: randomized clinical trial</title><author>Dudi-Venkata, N N ; Kroon, H M ; Bedrikovetski, S ; Lewis, M ; Lawrence, M J ; Hunter, R A ; Moore, J W ; Thomas, M L ; Sammour, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c267t-837d2fb0642e0c31f841f32efa3ffa6a415b3094f8087bdf9ebc26b136d4b7f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dudi-Venkata, N N</creatorcontrib><creatorcontrib>Kroon, H M</creatorcontrib><creatorcontrib>Bedrikovetski, S</creatorcontrib><creatorcontrib>Lewis, M</creatorcontrib><creatorcontrib>Lawrence, M J</creatorcontrib><creatorcontrib>Hunter, R A</creatorcontrib><creatorcontrib>Moore, J W</creatorcontrib><creatorcontrib>Thomas, M L</creatorcontrib><creatorcontrib>Sammour, T</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>British journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dudi-Venkata, N N</au><au>Kroon, H M</au><au>Bedrikovetski, S</au><au>Lewis, M</au><au>Lawrence, M J</au><au>Hunter, R A</au><au>Moore, J W</au><au>Thomas, M L</au><au>Sammour, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of STIMUlant and osmotic LAXatives (STIMULAX trial) on gastrointestinal recovery after colorectal surgery: randomized clinical trial</atitle><jtitle>British journal of surgery</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>108</volume><issue>7</issue><spage>797</spage><epage>803</epage><pages>797-803</pages><eissn>1365-2168</eissn><abstract>BACKGROUNDRecovery of gastrointestinal (GI) function is often delayed after colorectal surgery. Enhanced recovery protocols (ERPs) recommend routine laxative use, but evidence of benefit is unclear. This study aimed to investigate whether the addition of multimodal laxatives to an ERP improves return of GI function in patients undergoing colorectal surgery. METHODSThis was a single-centre, parallel, open-label RCT. All adult patients undergoing elective colorectal resection or having stoma formation or reversal at the Royal Adelaide Hospital between August 2018 and May 2020 were recruited into the study. The STIMULAX group received oral Coloxyl® with senna and macrogol, with a sodium phosphate enema in addition for right-sided operations. The control group received standard ERP postoperative care. The primary outcome was GI-2, a validated composite measure defined as the interval from surgery until first passage of stool and tolerance of solid intake for 24 h in the absence of vomiting. Secondary outcomes were the incidence of prolonged postoperative ileus (POI), duration of hospital stay, and postoperative complications. The analysis was performed on an intention-to-treat basis. RESULTSOf a total of 170 participants, 85 were randomized to each group. Median GI-2 was 1 day shorter in the STIMULAX compared with the control group (median 2  (i.q.r. 1.5-4) versus 3 (2-5.5) days; 95 per cent c.i. -1 to 0 days; P = 0.029). The incidence of prolonged POI was lower in the STIMULAX group (22 versus 38 per cent; relative risk reduction 42 per cent; P = 0.030). There was no difference in duration of hospital day or 30-day postoperative complications (including anastomotic leak) between the STIMULAX and control groups. CONCLUSIONRoutine postoperative use of multimodal laxatives after elective colorectal surgery results in earlier recovery of gastrointestinal function and reduces the incidence of prolonged POI. Registration number: ACTRN12618001261202 (www.anzctr.org.au).</abstract><doi>10.1093/bjs/znab140</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1365-2168
ispartof British journal of surgery, 2021-07, Vol.108 (7), p.797-803
issn 1365-2168
language eng
recordid cdi_proquest_miscellaneous_2542362085
source Oxford University Press Journals All Titles (1996-Current)
title Impact of STIMUlant and osmotic LAXatives (STIMULAX trial) on gastrointestinal recovery after colorectal surgery: randomized clinical trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T00%3A49%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20STIMUlant%20and%20osmotic%20LAXatives%20(STIMULAX%20trial)%20on%20gastrointestinal%20recovery%20after%20colorectal%20surgery:%20randomized%20clinical%20trial&rft.jtitle=British%20journal%20of%20surgery&rft.au=Dudi-Venkata,%20N%20N&rft.date=2021-07-01&rft.volume=108&rft.issue=7&rft.spage=797&rft.epage=803&rft.pages=797-803&rft.eissn=1365-2168&rft_id=info:doi/10.1093/bjs/znab140&rft_dat=%3Cproquest%3E2542362085%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2542362085&rft_id=info:pmid/&rfr_iscdi=true